Skip to main content
SpringerLink
Log in

Journal Club

Metaanalyse

  • JOURNAL CLUB
  • Published:
Medizinische Klinik Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Packer M, Bristow MR, Cohn JN. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349–1355.

    Article  CAS  PubMed  Google Scholar 

  2. CIBIS Investigators and Committees (CIBIS-II). The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial. Lancet 1999;353:9–13.

    Article  Google Scholar 

  3. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001–2007.

    Article  Google Scholar 

  4. Jouven X, Empana JP, Buyck JF, et al. Resting heart rate and its changes over years as a risk factor for mortality in the general population: the Paris Prospective Study. Eur Heart J 2006;27:Suppl:303.abstract.

    Google Scholar 

  5. Kannel WB, Kannel C, Paffenbarger RS Jr, et al. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987;113:1489–1494.

    Article  CAS  PubMed  Google Scholar 

  6. McAlister FA, Wiebe N Ezekowitz JA, et al. Meta analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure. Ann Intern Med 2009;150:784–794.

    PubMed  Google Scholar 

Literatur

  1. Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009;374:534–542.

    Article  CAS  PubMed  Google Scholar 

  2. Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous left atrial appendage closure vs. warfarin for stroke prevention in atrial fibrillation (PROTECT AF). I2 Summit Scientific Meeting. Annual Meeting of the American College of Cardiology (ACC), Orlando, FL, March 28, 2009:presentation number 2402-7.

  3. Fountain R, Holmes DR, Chandrasekaran K, et al. The PROTECT AF (WATCHMAN left atrial appendage system for embolic PROTECTion in patients with Atrial Fibrillation) trial. Am Heart J 2006;151:956–961.

    Article  PubMed  Google Scholar 

  4. Rash A, Downes T, Portner R, et al. A randomized controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO). Age Aging 2007;36:151–156.

    Article  Google Scholar 

  5. Block PC, Burstein S, Casale PN, et al. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) study. J Am Coll Cardiol Intv 2009;2:594–600.

    Google Scholar 

Literatur

  1. Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension prevalence and blood pressure levels in 6 european countries, Canada, and the United States. JAMA 2003;289:2363–2369.

    Article  PubMed  Google Scholar 

  2. Lenz T, Kuhlmann U, Hoyer J. Diagnostik und Therapie bei schwer einstellbarer Hypertonie. Dtsch Med Wochenschr 2009;134:813–817.

    Article  CAS  PubMed  Google Scholar 

  3. Sarafidis PA, Bakris GL. Resistant Hypertension. J Am Coll Cardiol 2008;52:1749–1757.

    Article  PubMed  Google Scholar 

  4. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicenter safety and proof-of-principle cohort study. Lancet 2009;373:1275–1281.

    Article  PubMed  Google Scholar 

  5. Routledge FS, McFetridge-Durdle JA, Dean CR. Night-time blood pressure patterns and target organ damage: a review. Can J Cardiol 2007;23:132–138.

    PubMed  Google Scholar 

Literatur

  1. Girard TD, Pandharipande PP, Ely EW. Delirium in the intensive care unit. Critical Care 2008;12:Suppl 3:S3.

    PubMed  Google Scholar 

  2. Van Rompaey B, Elseviers MM, Schuurmans MJ, et al. Risk factors for delirium in intensive care patients: a prospective cohort study. Crit Care 2009;13:R77.

    Article  PubMed  Google Scholar 

Literatur

  1. Chiche L, Forel JM, Roch A, et al. Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients. Crit Care Med 2009;37:1850–1857.

    Article  PubMed  Google Scholar 

  2. Kalil AC, Florescu DF. Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit Care Med 2009;37:2350–2358.

    Article  PubMed  Google Scholar 

  3. Hauber HP, Zabel P. [Pathophysiology and pathogens of sepsis.] Internist (Berl) 2009:50:779–780, 782–4, 786–7.

    Article  CAS  Google Scholar 

Literatur

  1. Zaman S, Sivagangabalan G, Narayan A, et al. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Circulation 2009;120:194–200.

    Article  CAS  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Journal Club. Med Klin 104, 817–827 (2009). https://doi.org/10.1007/s00063-009-1169-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00063-009-1169-5

Search

Navigation